Search results :

Telmisartan

More information: STITCH, PubChem and possibly Wikipedia

ATC Code: C09CA07

Side effects

Options: Show MedDRA Preferred Terms

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12 13 14
Intermittent claudication 7% - 8% 6% x x x
Upper respiratory tract infection rare — 6.5% - 7% 4.6% - 6% x x x x x x x x x x x x x x
Arthritis common x x x x x x x
Bronchitis common x x x x x x x
Infection common x x x x x x x x x x x x x x
Constipation common x x x x x x x
Gastritis common x x x x x x x
Arthropathy common x
Leg pain common x x x x x x x
Nervousness common x x x x x x x
Rhinitis common x x x x x x x
Skin disorder common x
Skin ulcer 3% - 4% 2% x x x
Influenza-like symptoms common, 1.7% 1.5% x x x x x x
Sinusitis rare — 2.2% - 3% 1.9% - 2% x x x x x x x x x x x x x x
Palpitations common, 0.6% 1% x x x x x x x
Sciatica uncommon, common x x x x x x x x
Arthralgia rare, common x x x x x x x x x x x x x x
Hypertension 1% 1.7% x
Pharyngitis rare — 1% - 1.1% 0% - 0.3% x x x x x x x x x x x x x x
Oedema peripheral 1% 1.2% x x x x x x
Dyspnoea very rare — common x x x x x x x x x x x x x x
Cardiac disorder uncommon x x x x x x x x
Mediastinal disorder uncommon x x x x x x x
Muscle spasms uncommon x x x x x x x x
Vertigo uncommon x x x x x x x x x x x x x x
Insomnia rare — common x x x x x x x x x x x x x x
Abnormal vision uncommon x x x x x x
Back pain postmarketing — 2.7% - 3% 0.9% - 1% x x x x x x x x x x x x x x
Diarrhoea postmarketing — 2.6% - 3% 1% - 2% x x x x x x x x x x x x x x
Flatulence rare, uncommon x x x x x x x x x x x x x x
Vomiting rare — 0.4% 1% x x x x x x x x x x x x x x
Electrocardiogram abnormal specific 0.2% 1% x
Abdominal pain postmarketing — common x x x x x x x x x x x x x x
Anaphylactic shock postmarketing, rare x x x x x x x x x x x
Anaemia postmarketing — uncommon x x x x x x x x x x x x x x
Angioedema postmarketing, rare x x x x x x x x x x x x x x
Anxiety rare, common x x x x x x x x x x x x
Asthenia postmarketing — uncommon x x x x x x x x x x x x
Atrial fibrillation postmarketing x x x
Mental disorder rare x x x x x x x x x
Chest pain postmarketing — 1.3% 1.2% x x x x x x x x x x x x x x
Connective tissue disorder rare x x x x x x x
Cough very rare — 1.4% - 1.6% 1.6% - 1.7% x x x x x x x x x x x x x x
Cystitis rare, uncommon x x x x x x x x x x x x x x
Drug eruption postmarketing, rare x x x x x x x x x x x
Dizziness postmarketing — 3.6% 4.6% x x x x x x x
Dysgeusia rare x x x
Dyspepsia postmarketing — 1.6% 1.2% x x x x x x x x x x x x x x
Eczema rare, common x x x x x x x x x x x x x x
Oedema postmarketing, common x x x x
Eosinophilia postmarketing, rare x x x x x x x x x x x x
Rash postmarketing — common x x x x x x x x x x x x x x
Eye disorder rare, uncommon x x x x x x x x
Fatigue postmarketing, 3.2% 3.3% x x x x x x x
Headache postmarketing — 8% 15.6% x x x x x x x
Cardiac failure congestive postmarketing x x x
Hyperhidrosis rare, uncommon x x x x x x x x
Hyperkalaemia postmarketing — uncommon x x x x x x x x x x x x
Hypersensitivity postmarketing, rare x x x x x x x x x x x x x x
Hypoglycaemia postmarketing, rare x x x x x x x x x x x
Hypotension postmarketing, uncommon x x x x x x x
Orthostatic hypotension postmarketing, uncommon x x x x x x x x x x x x
Immune system disorder rare x x x x x x x x
Renal failure acute postmarketing, uncommon x x x x x x x x x x x x
Cramps of lower extremities postmarketing, common x x x x x x x
Liver disorder postmarketing, rare x x x x x x x x x x x x
Cramp muscle postmarketing x x x
Myocardial infarction postmarketing x x x
Nausea postmarketing — 1.1% 1.4% x x x x x x x
Nervous system disorder rare x x x x x x x x
Pain postmarketing — 3.5% 4.3% x x x x x x x x x
Pruritus rare, uncommon x x x x x x x x x x x x x x
Rhabdomyolysis postmarketing x x x x
Syncope postmarketing — uncommon x x x x x x x x x x x x
Tachycardia rare x x x x x x x x x x x x x x
Tendonitis postmarketing — uncommon x x x x x x x x x x x
Tenosynovitis postmarketing x x x
Thrombocytopenia postmarketing, rare x x x x x x x x x x x x
Erythema postmarketing, rare x x x x x x x x x x x x
Urinary tract infection postmarketing — uncommon x x x x x x x x x x x x x x
Urinary tract disorder rare x x x x x x x x x
Urticaria postmarketing, rare x x x x x x x x x x x x x
Angiopathy rare, uncommon x x x x x x x x
Dry mouth rare, uncommon x x x x x x x x x x x x x x
Hepatic function abnormal rare x x x x x x x x
Haemoglobin decreased rare x x x x x x x x
Malnutrition rare x x x x x x x x x
Unspecified disorder of skin and subcutaneous tissue rare x x x x x x x x
Fatal outcomes postmarketing, rare x x x x x x x x x x x
Myalgia postmarketing — 1.1% 0.7% x x x x x x x x x x x x x x
Tendon pain postmarketing, rare x x x x x x x x x x x
Upset stomach rare x x x x x x x x x
Blood uric acid increased rare x x x x x x x x
Blood creatinine increased rare, uncommon x x x x x x x x x x x x x x
Hypertension worsened postmarketing x x x
Hepatic enzyme increased rare x x x x x x x x
Edema of lower extremities postmarketing x x x
Diabetic postmarketing, rare x x x x x x x x x x
Erectile dysfunction postmarketing x x x x x x
Sepsis rare x x x x x x x x
Hepatobiliary disease rare x x x x x x x x
Anxiety depression rare x x
Bradycardia postmarketing — uncommon x x x x x x x x x x x x
Blood pressure increased postmarketing x x x
Toxic skin eruption postmarketing, rare x x x x x x x x x x x
Influenza like illness rare x x x x x x x x
Face oedema postmarketing x x x
Visual disturbance rare x x x x x x x
Sweating increased postmarketing, uncommon x x x x x x
Ear and labyrinth disorders rare x x x x x x x x
Blood creatine phosphokinase increased rare x x x x x x x
Renal impairment postmarketing, uncommon x x x x x x x x x x x x
Uric acid increased postmarketing x x x
Somnolence rare — 0.4% 1% x x x x x x x x x x x x x x
Gastrointestinal disorder very rare, uncommon x x x x x x x x x x x x x x
Lung disorder very rare x x
Abscess x x x x x x x
Angina pectoris x x x x
Anorexia x
Arrhythmia x
Asthma x x x x x x
Bone disorder x
Breast disorder x
Bronchospasm x
Bursitis x
Cardiovascular disorder x
Cerebrovascular disorder x x x x x x x
Conjunctivitis x x x x x x x
Dermatitis x x x x x x
Dysuria x
Ear pain x x x x x x
Enteritis x x x x x x
Epistaxis x x x x x x x
Body temperature increased x x x x x x x
Flushing x x x x x x
Gastroenteritis x x x x x x x
Gastrooesophageal reflux disease x x x x x x x
Gout x x x x x x
Haematuria x
Haemorrhoids x x x x x x
Hypercholesterolaemia x x x x x x x
Hypoaesthesia x x x x x x
Hypokalaemia x
Melaena x
Hypertonia x
Fungal infection x x x x x x
Myositis x
Otitis media x x x x x x x
Pain in extremity x x x x x x
Paraesthesia x x x x x x
Neuropathy peripheral x
Pneumonia x
Purpura x
Renal failure x
Tinnitus x x x x x x
Toothache x x x x x x
Pollakiuria x x x x x x
Micturition disorder x
Vaginal inflammation x
Disorder sight x
Plantar fasciitis x
Migraine x x x x x x
Muscular weakness x
Dry skin x
Interstitial lung disease x x x x x x x
Red blood cell disorders x
Malaise x x x x x x
Increased appetite x
Muscle contractions involuntary x x x x x x
Gravitational oedema x x x x x x
Leg edema x x x x x x x
Arthritis aggravated x
Migraine aggravated x
Genital candidiasis x
Enlargement abdomen x
Rigors x
Electrocardiogram abnormal x x x x x
Cholesterol serum elevated x
Hyperuricaemia x
Infestation NOS x x x x x x x x
Blood and lymphatic system disorders x
Raised serum uric acid x
Unspecified disorder of autonomic nervous system x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

TELMISARTAN / MICARDIS 80MG TAB

Side effects:114
Source:Health Canada

telmisartan / telmisartan

Side effects:80
Source:EMA

telmisartan / telmisartan

Side effects:79
Source:EMA

telmisartan / telmisartan

Side effects:80
Source:EMA

telmisartan / telmisartan

Side effects:79
Source:EMA

telmisartan / telmisartan

Side effects:80
Source:EMA

telmisartan / telmisartan

Side effects:79
Source:EMA

telmisartan / telmisartan

Side effects:81
Source:EMA

TELMISARTAN / MICARDIS

Side effects:79
Source:FDA

telmisartan / Micardis

Side effects:80
Source:FDA

TELMISARTAN

Side effects:111
Source:FDA Structured Product Label

TELMISARTAN

Side effects:113
Source:FDA Structured Product Label

TELMISARTAN

Side effects:114
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label